|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal metastases显示文摘AIM:To systematically review the available evidence regarding cytoreductive surgery(CRS) and intraperitoneal chemotherapy(IPC) for colorectal peritoneal metastases(CPM).METHODS:An electronic literature search was carried out to identify publications reporting oncological outcome data(overall survival and/or disease free survival and/or recurrence rates)following CRS and IPC for treatment of CPM.Studies reporting outcomes following CRS and IPC for cancer subtypes other than colorectal were only included if data were reported independently for colorectal cancer-associated cases;in addition studies reporting outcomes for peritoneal carcinomatosis of appendiceal origin were excluded.RESULTS:Twenty seven studies,published between1999 and 2013 with a combined population of 2838patients met the predefined inclusion criteria.Included studies comprised 21 case series,5 case-control studies and 1 randomised controlled trial.Four studies provided comparative oncological outcome data for patients undergoing CRS in combination with IPC vs systemic chemotherapy alone.The primary indication for treatment was CPM in 96%of cases(2714/2838)and recurrent CPM(rCPM)in the remaining 4%(124/2838).In the majority of included studies(20/27)CRS was combined with hyperthermic intraperitoneal chemotherapy(HIPEC).In 3 studies HIPEC was used in combination with early post-operative intraperitoneal chemotherapy(EPIC),and 2 studies used EPIC only,following CRS.Two studies evaluated comparative outcomes with CRS+HIPEC vs CRS+EPIC for treatment of CPM.The delivery of IPC was performed using an'open'or'closed'abdomen approach in the included studies.CONCLUSION:The available evidence presented in this review indicates that enhanced survival times can be achieved for CPM after combined treatment with CRS and IPC. | Reza Mirnezami Brendan J Moran Kate Harvey Tom Cecil Kandiah Chandrakumaran Norman Carr Faheez Mohamed Alexander H Mirnezami | 2014 | World Journal of Gastroenterology2014，20，38： | 6 |
| 2 | Pseudomyxoma peritonei显示文摘Pseudomyxoma peritonei (PMP) is an uncommon 'bor-derline malignancy' generally arising from a perforated appendiceal epithelial tumour. Optimal treatment involves a combination of cytoreductive surgery (CRS) with heated intraperitoneal chemotherapy (HIPEC). Controversy persists regarding the pathological classification and its prognostic value. Computed tomography scanning is the optimal preoperative staging technique. Tumour marker elevations correlate with worse prognosis and increased recurrence rates. Following CRS with HIPEC, 5-year survival ranges from 62.5% to 100% for low grade, and 0%-65% for high grade disease. Treat-ment related morbidity and mortality ranges from 12 to 67.6%, and 0 to 9%, respectively. Surgery and HIPEC are the optimal treatment for PMP which is at best a 'borderline' peritoneal malignancy. | Katharine E Bevan Faheez Mohamed Brendan J Moran | 2010 | World Journal of Gastrointestinal Oncology2010，2，1： | 4 |
| 3 | Thermal Enhancement of New Chemotherapeutic Agents at Moderate Hyperthermia显示文摘 | Faheez Mohamed MBChB MRCS Pierre Marchettini MD O. Anthony Stuart BS M. Urano MD Paul H. Sugarbaker MD FACS FRCS | 2003 | Annals of Surgical Oncology2003，，4： | 3 |
| 4 | Extent of parietal peritonectomy does not change intraperitoneal chemotherapy pharmacokinetics显示文摘 | Vinicius Lima Vazquez O. Anthony Stuart Faheez Mohamed Paul H. Sugarbaker | 2003 | Cancer Chemotherapy and Pharmacology2003，，2： | 2 |
| 5 | Operative Findings, Early Complications, and Long-Term Survival in 456 Patients With Pseudomyxoma Peritonei Syndrome of Appendiceal Origin显示文摘 | Haney Youssef Christopher Newman Kandiah Chandrakumaran Faheez Mohamed Tom D. Cecil Brendan J. Moran | 2011 | Diseases of the Colon & Rectum2011，，： | 1 |
| 6 | Iterative procedures combining cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal recurrence: Postoperative and long‐term results显示文摘 | Nicolas Golse Naoual Bakrin Guillaume Passot Faheez Mohamed Delphine Vaudoyer Fran?ois‐N?el Gilly Olivier Glehen Eddy Cotte | 2012 | J Surg Oncol2012，，2： | 1 |
| 7 | Pharmacokinetics and tissue distribution of intraperitoneal paclitaxel with different carrier solutions显示文摘 | Faheez Mohamed Pierre Marchettini O. Anthony Stuart Paul H. Sugarbaker | 2003 | Cancer Chemotherapy and Pharmacology2003，，5： | 1 |
| 8 | Progression Following Neoadjuvant Systemic Chemotherapy May Not Be a Contraindication to a Curative Approach for Colorectal Carcinomatosis显示文摘 | Guillaume Passot Delphine Vaudoyer Eddy Cotte Benoit You Sylvie Isaac Fran?ois No?l Gilly Faheez Mohamed Olivier Glehen | 2012 | Annals of Surgery2012，，1： | 1 |
| 9 | Outcome of 'Kissing Stents' for Aortoiliac Atherosclerotic Disease, Including the Effect on the Non-diseased Contralateral Iliac Limb显示文摘 | Faheez Mohamed B. Sarkar G. Timmons A. Mudawi H. Ashour R. Uberoi | 2002 | CardioVascular and Interventional Radiology2002，，6： | 1 |
| 10 | Laparoscopic total colectomy: Does the indication influence the outcome?显示文摘AIM: To assess and compare outcomes of laparoscopic total colectomy performed for a variety of indications. METHODS: Sixty six patients underwent laparoscopic total colectomy for inflammatory bowel disease (IBD) (13) and other diseases (53). Data on demographics, pre and post-operative outcomes were collected prospectively.RESULTS: Mean operative time was 4.5 h. Conversion rate was 13.6%. Total colectomy performed for IBD was associated with a signifi cantly higher anastomotic leak rate (23.1% vs 1.9%, P < 0.05). On univariate analysis, hand sewn anastomosis and treatment with more than 20 mg of prednisolone for at least 3 mo was associated with a higher anastomotic leak rate (P < 0.05). No signifi cant difference was found in return of gut function and overall morbidity between disease groups. CONCLUSION: Laparoscopic total colectomy is feasible and outcomes are equivalent whatever the indica- tion, except for anastomotic leak rate which is higher for patients with IBD. | Eddy Cotte Faheez Mohamed Stéphane Nancey Yves Franois Olivier Glehen Bernard Flourié Jean-Christophe Saurin Gilles Poncet | 2011 | World Journal of Gastrointestinal Surgery2011，3，11： | 1 |
| 11 | Progression Following Neoadjuvant Systemic Chemotherapy May Not Be a Contraindication to a Curative Approach for Colorectal Carcinomatosis显示文摘 | Guillaume Passot Delphine Vaudoyer Eddy Cotte Benoit You Sylvie Isaac Fran?ois No?l Gilly Faheez Mohamed Olivier Glehen | 2012 | Annals of Surgery2012，，1： | 1 |
| 12 | Cytoreductive Surgery and Intraperitoneal Chemohyperthermia for Chemoresistant and Recurrent Advanced Epithelial Ovarian Cancer: Prospective Study of 81 Patients显示文摘 | Eddy Cotte Olivier Glehen Faheez Mohamed Franck Lamy Claire Falandry Fran?ois Golfier Francois Noel Gilly | 2007 | World Journal of Surgery2007，，9： | 1 |
| 13 | Cytoreductive Surgery and Intraperitoneal Chemohyperthermia for Chemoresistant and Recurrent Advanced Epithelial Ovarian Cancer: Prospective Study of 81 Patients显示文摘 | Eddy Cotte Olivier Glehen Faheez Mohamed Franck Lamy Claire Falandry Fran?ois Golfier Francois Noel Gilly | 2007 | World Journal of Surgery2007，，9： | 1 |
| 14 | Thermal Enhancement of New Chemotherapeutic Agents at Moderate Hyperthermia显示文摘 | Faheez Mohamed MBChB MRCS Pierre Marchettini MD O. Anthony Stuart BS M. Urano MD Paul H. Sugarbaker MD FACS FRCS | 2003 | Annals of Surgical Oncology2003，，4： | 1 |
| 15 | Cytoreductive Surgery With Intraperitoneal Chemohyperthermia for the Treatment of Pseudomyxoma Peritonei: A Prospective Study显示文摘 | Rasmy Loungnarath Sylvain Causeret Nadine Bossard Mohamed Faheez Annie-Claude Sayag-Beaujard Cécile Brigand Fran?ois Gilly Olivier Glehen | 2005 | Diseases of the Colon & Rectum2005，，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员